Format

Send to

Choose Destination
Epilepsy Behav. 2017 Aug;73:208-213. doi: 10.1016/j.yebeh.2017.05.035. Epub 2017 Jun 23.

An analysis of quality of life (QOL) in patients with epilepsy and comorbid psychogenic nonepileptic seizures (PNES) after vagus nerve stimulation (VNS).

Author information

1
Department of Neurosurgery, University of South Florida, Tampa, FL, United States.
2
Department of Neurology, Dartmouth Hitchcock Medical Center, Lebanon, NH, United States.
3
Department of Neurosurgery, University of South Florida, Tampa, FL, United States; Department of Neurology, University of South Florida, Tampa, FL, United States.
4
Department of Neurosurgery, University of South Florida, Tampa, FL, United States; Department of Neurology, University of South Florida, Tampa, FL, United States. Electronic address: fvale@health.usf.edu.

Abstract

PURPOSE:

Patients with epilepsy (PWE) may suffer from comorbid psychogenic nonepileptic seizures (PNES). The efficacy of vagus nerve stimulation (VNS) in the treatment of epilepsy and depression is established, however the impact on PNES is unknown. Since many patients with PNES have comorbid depression, we explored the impact on quality of life (QOL) that VNS has on PWE and PNES.

METHODS:

The video electroencephalogram (vEEG) of all patients who underwent VNS at our institution was reviewed. Patients diagnosed with both psychogenic seizures and epileptic seizures on their vEEG were included in this study. These patients were contacted, and given a QOLIE-31 survey to assess their quality of life after VNS. Patients also completed a separate survey created by our group to categorize the quartile of their improvement. Pre-operative psychiatric disease was retrospectively reviewed.

RESULTS:

From a period of 2001 to 2016, 518 patients underwent placement of VNS for drug resistant epilepsy (DRE) at our institution. In total, 16 patients were diagnosed with both epilepsy and PNES. 11/16 patients responded to our questionnaire and survey. 9 out of 11 patients felt that their epileptic seizures had improved after VNS, while 7 of the 11 patients felt that their psychogenic episodes had improved. 2(28.6%), 1 (14.3%), and 4 (57.1%) of participants said their PNES improved by 25-50%, 50-75%, and 75-100%, respectively. 3(27.3%), 3 (27.3%), 1 (9.1%), and 4 (36.4%) of the participants said their epileptic seizures improved by 0-25%, 25-50%, 50-75%, and 75-100%, respectively. The average overall score for quality of life for the study participants was found to be 51 (±8) out of 100.

CONCLUSION:

Patients with epilepsy and comorbid PNES may benefit from VNS. It is unclear whether the benefit is conferred strictly from decreased epileptic seizure burden. The possible effect on PNES may be related to the known effect of VNS on depression. Further studies are necessary to elucidate the role of VNS in the treatment of PNES and possibly other psychiatric disease.

KEYWORDS:

Epilepsy; Pseudoseizure; Psychogenic nonepileptic seizure; VNS; Vagus Nerve Stimulation

PMID:
28651170
DOI:
10.1016/j.yebeh.2017.05.035
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center